On August 4, 1998 Asensio & Company, Inc. announced that it had initiated research coverage of shares of Turbodyne Technologies, Inc.’s (NASDAQ Symbol: TRBD) (Price: $5.3437) common stock. Following the initiation of coverage, trading was […]
Hemispherx Biopharma, Inc. (AMEX: HEB) (Price: $13.625) announced in press releases on December 16, 1999 and February 22, 2000 that it presented HIV test findings at a conference sponsored by Search For A Cure, a […]
“Boiler Room” Critics Find A Debit Even in the credits – The New York Times
Short-Selling Contest Ends in a Tie – Bloomberg News
On December 9, 1999, Turbodyne Technologies, Inc. (Trading Symbol: TRBD) (Price: $5.3437) announced the Board of Directors had retained a new Disclosure Committee. The Committee consisted of three members: Senator Lawrence L. Pressler, Charles R. […]
Able Telcom Holding Corp. (NASDAQ: ABTE) (Price: $10.9375) yesterday announced that the U.S. Securities & Exchange Commission (“SEC”) has “concerns” regarding the accounting and disclosures of its acquisition of MFS Network Technologies, Inc. (“NT”) from […]
On November 17, 1999 the Enforcement Section of the Massachusetts Securities Division commenced a proceeding against Whale Securities Co., L.P. (“Whale”) and James D. Whitten, a principal, part-owner and registered representative of Whale. The State […]
The Problem with ParkerVision – Fortune
Tale of Whale’s Offerings Is a Bit of a Downer – The Wall Street Journal
ParkerVision plunges on stock fraud allegations – Bridge News
ParkerVision plunges on stock fraud allegations – Bridge News
An article in last Friday’s Wall Street Journal titled “Disclosure Issue Hits White-Shoe Manager” resulted from Neuberger Berman, Inc.’s (NYSE: NEU) and Jack M. Ferraro’s roles in ParkerVision, Inc.’s (NASDAQ: PRKR) (Price: $25.125) stock promotion. […]
Disclosure Issue Hits White-Shoe Manager – The Wall Street Journal
Disclosure Issue Hits White-Shoe Manager – The Wall Street Journal
Banca del Gottardo (“Gottardo”) acted as agent for two ParkerVision, Inc. (NASDAQ: PRKR) (Price: $25.25) offshore stock sales totaling 1.7 million shares. ParkerVision granted 305,000 warrants to Neuberger Berman, Inc.’s (NYSE: NEU) Jack M. Ferraro […]
An article posted last night on the Fortune magazine website titled “The ParkerVision Party” provides further information about the tainted cast of characters behind the ParkerVision, Inc. (NASDAQ: PRKR) (Price: $25.25) fraud. The author of […]
The ParkerVision Party – Fortune.com
Yesterday, ParkerVision, Inc. (NASDAQ: PRKR) (Price: $25.25) finally announced its long-awaited Symbol Technologies, Inc. (NYSE: SBL) licensing agreement. The agreement had been disclosed long before the announcement, and ParkerVision had already received payment. As expected, […]
Yesterday, ParkerVision, Inc.’s (NASDAQ: PRKR) (Price: $25.25) Chairman and CEO Jeffrey Parker claimed that the long-awaited Symbol Technologies, Inc. (NYSE: SBL) licensing agreement represents “a major recognition of our technology.” Yet ParkerVision refused to disclose […]
Until recently, it was difficult to ascertain specific details of the fraudulent D2D claims made by ParkerVision, Inc. (NASDAQ: PRKR) (Price: $24.3125). Previously, ParkerVision’s technology claims had to be extracted from over three and a […]
Yesterday, ParkerVision, Inc. (NASDAQ: PRKR) (Price: $22.75) issued a press release in response to Asensio & Company, Inc.’s Strong Sell recommendation. ParkerVision’s press release failed to deny that ParkerVision is neither an IC nor a […]
Network Solutions, Inc. (NASDAQ: NSOL) (Price: $85.50) has finally succumbed to the U.S. Department of Commerce’s (“DOC”) demand that it must recognize ICANN’s regulatory authority and apply to ICANN for accreditation if it desires to […]
Whale blubber – Forbes
Avant! Shares Surge 60% On Court Ruling in Dispute – Dow Jones Newswire
ParkerVision: Stock falls on Asensio rumor – The Florida Times Union
Parker’s vision is questioned – The Florida Times Union
23 Reasons Wall Street hates Manuel Asensio – Worth magazine
Burnt Offerings As’ Net stocks fall, IPO cuts price – Barron’s
In a Hemispherx Biopharma, Inc. (AMEX: HEB) (Price: $6.25) Securities and Exchange Commission Form S-3 registration statement dated June 23, 1999, Hemispherx has filed to register approximately 2.1 million shares of insider, unregistered common stock […]
VIA FEDERAL EXPRESS AND FACSIMILE: (301) 827-5562 August 4, 1999 Mr. David T. Read Acting Director of Regulatory Policy Staff Center for Drug Evaluation and Research U.S. Food and Drug Administration (HFD-7) 5600 Fishers Lane […]
© Asensio.com. All rights reserved.